Document:

Restricted Stock Agreement

 Exhibit 10.3 
 February 24, 2006 
 «Prx» «Employee» 
 «Street_Address» 
 «City», «State» «Zip» 
  

	Re:	Restricted Stock Agreement Between Nabi Biopharmaceuticals and «Employee» 

 Dear «Prx» «Employee_Last_Name»: 
 I am pleased to report that for good and valuable
consideration, receipt of which is hereby acknowledged, Nabi Biopharmaceuticals, a Delaware corporation (the “Company”), does hereby award to you (the “Awardee”)
             «Award_Spelled» («Total_Award») shares of Common Stock of the Company (the “Shares”), effective February 24, 2006 (the
“Date of Award”) pursuant to the terms of the Company’s 2000 Equity Incentive Plan, as amended (the “Plan”), and the terms and conditions set forth below in this Restricted Stock Agreement. A copy of the Plan is attached
hereto and is incorporated herein in it entirety by reference. 
 The Awardee hereby accepts the Shares subject to all of the provisions of
the Plan, and upon the following additional terms and conditions: 
 1. (a) The Shares shall become fully vested (i.e. nonforfeitable)
(i) if the Awardee is employed by the Company on March 1, 2009; (ii) if the Awardee is employed by the Company at the time a Change of Control (as defined below) occurs; (iii) in the event the Awardee’s employment by the
Company is terminated after March 1, 2008 by the Company without Cause (as defined below) or by the Awardee within thirty (30) days after an event that constitutes Good Reason (as defined below) has occurred; or (iv) upon the
Awardee’s death (including Awardee’s death within 90 days after Awardee’s active employment by the Company has ceased due to disability). In the event that Awardee’s employment by the Company terminates prior to March 1,
2009 before the Shares have become fully vested (except to the extent provided in the Plan or as provided above in clause (iii) or (iv)), the Shares will be forfeited to the Company automatically and without notice to the Awardee on the date
the Awardee’s employment is so terminated. 
 (b) As used herein, “Cause” shall mean (i) illegal or disreputable conduct
which impairs the reputation, good will or business of the Company or involves the misappropriation of funds or other property of the Company, (ii) willful misconduct by the Awardee or willful failure to perform his or her responsibilities in
the best interests of the Company (including, without limitation, breach by the Awardee of any provision of any employment, advisory, consulting, nondisclosure, non-competition or other agreement between the Awardee and the Company or any subsidiary
of the Company, (iii) refusal or failure to carry out any employment duties reasonably assigned to the Awardee other than by reason of death or disability, or (iv) demonstrated negligence or gross inefficiency in the execution of the
Awardee’s employment duties for the Company. Any resignation in anticipation of discharge for Cause that is accepted by the Company in lieu of a formal discharge for cause shall be deemed a termination of employment for Cause for purposes
hereof. 
 (c) A “Change of Control” shall be deemed to have taken place if (i) any “person” (as such term is used
in Sections 13(d) and 14(d)(2) of the Exchange Act) is or becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the
combined voting power of the Company’s then outstanding securities; (ii) (A) a reorganization, merger or consolidation, in each case, with respect to which persons who were shareholders of the Company immediately prior to such
reorganization, merger or consolidation do not, immediately thereafter, own more than 50% of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated company’s then outstanding
voting securities or (B) a liquidation or dissolution of the Company; or (iii) as the result of a tender offer, exchange offer, merger, consolidation, sale of assets or contested solicitation of proxies or stockholder consents or any

 
combination of the foregoing transactions (a “Transaction”), the persons who were directors of the Company immediately before the Transaction shall
cease to constitute a majority of the Board of Directors of the Company or of any parent of or successor to the Company immediately after the Transaction occurs. 
 (d) As used herein, “Good Reason” shall mean: 
 (i) The assignment to the Awardee of any duties
inconsistent in any material adverse respect with the Awardee’s position (including status, offices, titles and reporting requirements), authority, duties or responsibilities as in effect on March 1, 2008, or any other action by the
Company which results in a diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after
receipt of notice from the Awardee; 
 (ii) Any reduction of the Awardee’s base salary or the failure by the Company to provide the
Awardee with an incentive compensation program, welfare benefits, retirement benefits and other benefits which in the aggregate are no less favorable than the benefits to which the Awardee was entitled prior to March 1, 2008; or 
 (iii) The Company’s requiring the Awardee to be based at any office or location more than 15 miles from that location at which he or she is
employed on March 1, 2008, except for travel reasonably required in the performance of his or her responsibilities. 
 2. Until they
vest, the Shares are referred to herein as “Restricted Stock.” Except as otherwise set forth herein, Restricted Stock shall not be transferred, assigned, pledged or otherwise encumbered during the period beginning on the Award Date and
ending on date that the Shares vest pursuant to Section 1 (the “Restricted Period”). Any attempt at any transfer, assignment, pledge, or other disposition during the Restricted Period shall be null and void and without effect and
shall cause the immediate forfeiture of all shares of Restricted Stock. Restricted Stock that is forfeited shall be immediately transferred to the Company without any payment by the Company. The Company shall have the full right to cancel
certificates evidencing such forfeited shares automatically upon such forfeiture, whether or not such certificates shall have been surrendered to the Company. Following such forfeiture, the Awardee shall have no further rights with respect to such
forfeited shares of Restricted Stock. 
 3. Promptly following the date the Shares vest, the Company shall deliver to the Awardee or the
person or persons to whom rights under this Agreement shall have passed by bequest or inheritance, as the case may be, a stock certificate for the Shares free of the restrictions and legend set forth in this Agreement. 
 4. Any stock certificate representing the Restricted Stock awarded hereunder shall be: (i) affixed with the following legend: “The shares
represented by this certificate are subject to forfeiture and restrictions on transfer pursuant to the terms of a Restricted Stock Agreement between the Company and the record holder of this certificate, a copy of which is available for inspection
at the offices of the Company or may be made available upon request;” and (ii) deposited with the Company, together with a stock power endorsed by the Awardee in blank (in the form attached as Exhibit A hereto). At the expiration of the
Restricted Period, as set forth herein, the Company shall deliver any such certificates to the Awardee. Absent willful misconduct by the Company, it shall be exempted from any responsibility or liability for any delivery or delay in delivery
pursuant to this Agreement and for any other act or omission. 
 5. Subject to the restrictions contained in this Agreement, Awardee shall
have the rights of a stockholder with respect to the Shares, including the right to vote the Shares, including Restricted Stock, and to receive all dividends, cash or stock, paid or delivered thereon, from and after the date hereof. Forfeiture of
Restricted Stock pursuant to this Agreement shall not create any obligation to repay dividends received as to such Restricted Stock during the Restricted Period, nor shall such forfeiture invalidate any votes given by Awardee with respect to such
Shares prior to forfeiture. 

 6. The parties hereto recognize that the Company may be obligated to withhold federal, state and local
income taxes and social security taxes to the extent that the Awardee realizes ordinary income in connection with the vesting of the Restricted Stock or the payment of dividends on the Restricted Stock. The Awardee agrees that the Company or a
subsidiary or an affiliate of the Company may withhold amounts needed to cover such taxes from payments otherwise due and owing to the Awardee, and also agrees that upon demand by the Company the Awardee will immediately pay to the Company any
additional amounts as may be necessary to satisfy such withholding tax obligation. Such payment shall be made in cash or cash equivalent. 
 7. Awardee acknowledges and agrees that nothing herein or in the Plan, nor any of the rights granted hereunder or thereunder to Awardee, shall be construed to (a) give Awardee the right to remain employed by the Company or to continue
to receive any employee benefits, or (b) in any manner restrict the right of the Company to modify, amend or terminate any of its employee benefit plans. 
 8. Any and all grants or deliveries of Shares hereunder shall constitute special incentive payments to the Awardee and shall not be taken into account in computing the amount of salary or compensation of the Awardee
for the purpose of determining any pension, retirement, death or other benefits under (a) any pension, retirement, profit-sharing, bonus, life insurance, 401(k) or other employee benefit plan of the Company, or any of their affiliates, or
(b) any agreement between the Company or any of their affiliates on the one hand, and the Awardee on the other hand, except as such plan or agreement shall otherwise expressly provide or may otherwise provide following a Change of Control.

 9. The law of the State of Delaware, except its law with respect to choice of law, shall be controlling in all matters relating to this
Agreement. 
 10. This Agreement embodies the entire agreement of the parties hereto with respect to the Shares awarded hereunder, and all
other matters contained herein. This Agreement supersedes and replaces any and all prior oral or written agreements with respect to the subject matter hereof. This Agreement may be amended, and any provision hereof waived, but only in writing signed
by the party against whom such amendment or waiver is sought to be enforced. A waiver on one occasion shall not be deemed to be a waiver of the same or any other breach on a future occasion. If there is any inconsistency between the provisions of
this Agreement and of the Plan, the provisions of the Plan shall govern. 
 WITNESS the execution hereof as of 24th day of February, 2006. 
  

			
	Nabi Biopharmaceuticals
		
	By	 	  

		 	Thomas H. McLain, Chairman
		 	Chief Executive Officer & President

 By signing this Restricted Stock Agreement below, the Awardee hereby acknowledges and agrees
that he/she has read, understands and accepts and agrees to all of the terms and conditions set forth herein and set forth in the Nabi 2000 Equity Incentive Plan 
  

	
	  

	Awardee Signature
	
	  

	Print Name

 Exhibit A 
 STOCK TRANSFER POWER 
 FOR VALUE RECEIVED, I hereby sell, assign and transfer unto Nabi
Biopharmaceuticals
                                        
(            ) shares of Common Stock of Nabi Biopharmaceuticals standing in my name on the books of said corporation and represented by stock certificate
no.             representing all of such shares and hereby irrevocably constitute and appoint
                            , attorney for such transfer of said stock on the books of said
corporation with full power of substitution in the premises. 
  

									
	Dated	 	  
	 		 	  

					
		 		 		 	Print name:Letter Agreement for Stock Option

 Exhibit 10.4 
 February 24, 2006 
  

	Re:	Letter Agreement for Stock Option Grant and Acceptance Between 

 Nabi Biopharmaceuticals and XXXXXXXXXX 
 Dear XXXXXXXX: 
 I am pleased to report that for good and valuable consideration, receipt of which is hereby acknowledged, Nabi Biopharmaceuticals, a Delaware corporation
(the “Company”), does hereby grant to you (the “Optionee”) an option to purchase XXXXX shares of Common Stock of the Company (the “Option”), pursuant to the terms of the Company’s 2000 Equity Incentive Plan, as
amended (the “Plan”), and the terms and conditions set forth below. A copy of the Plan is attached hereto and is incorporated herein in its entirety by reference. 
 The Optionee hereby accepts the Option subject to all of the provisions of the Plan, and upon the following additional terms and conditions: 

1. The price at which the shares of Common Stock may be purchased pursuant to the Option is $3.83 per share, subject to adjustment as provided
in the Plan. 
 2. (a) The Option shall expire at the close of business on the tenth anniversary of the date hereof (the
“Expiration Date”). Subject to the following provisions of this Section 2 and to the provisions of the Plan, the Option shall be exercisable, to the extent of the full number of shares covered hereby, before said Expiration Date as
follows: (i) if the Optionee is employed by the Company on March 1, 2009; (ii) if the Optionee is employed by the Company upon a Change of Control (as defined below); or (iii) in the event the Optionee’s employment by the
Company is terminated after March 1, 2008 by the Company without Cause (as defined below) or by the Optionee for Good Reason (as defined below), less at any time the number of shares as to which the Option has been exercised previously. The
Option shall not be exercised at all prior to March 1, 2009 (except to the extent provided in the Plan or this Section 2) or after the Expiration Date. 
 (b) If the Optionee’s employment is terminated by the Company for “Cause”, the Option shall terminate automatically and without notice to the Optionee on the date the Optionee’s employment is
terminated. As used herein, “Cause” shall mean (i) illegal or disreputable conduct which impairs the reputation, good will or business of the Company or involves the misappropriation of funds or other property of the Company,
(ii) willful misconduct by the Optionee or willful failure to perform his or her responsibilities in the best interests of the Company (including, without limitation, breach by the Optionee of any provision of any employment, advisory,
consulting, nondisclosure, non-competition or other agreement between the Optionee and the Company or any subsidiary of the Company, (iii) refusal or failure to carry out any employment duties reasonably assigned to the Optionee other than by
reason of death or disability, or (iv) demonstrated negligence or gross inefficiency in the execution of the Optionee’s employment duties for the Company. Any resignation in anticipation of discharge for Cause that is accepted by the
Company in lieu of a formal discharge for cause shall be deemed a termination of employment for Cause for purposes hereof. 
 (c) If the
Optionee dies while employed by the Company or within ninety (90) days after the Optionee ceases active employment due to disability, each option held by the Optionee immediately prior to death may be exercised, to the extent it was exercisable
immediately prior to death, by the Optionee’s executor or administrator or by the person or persons to whom the option is transferredby will or the applicable laws of descent and distribution, at any time within a one-year period beginning with
the date of the Optionee’s death, but in no event beyond the Expiration Date. 
 2000 Equity Incentive Plan 

 (d) Notwithstanding the provisions of Section 8(D) of Optionee’s Employment Agreement effective
as of XXXXXXXXXX, but subject to the provisions of Section 2(d) of Optionee’s Change of Control Severance Agreement effective as of XXXXXXXXXXX, if the Optionee’s employment with the Company terminates for any reason other than Cause,
Good Reason or death, all options held by the Optionee that are not then exercisable, shall terminate. Options that are exercisable as of the date employment terminates shall be exercisable by the Optionee during the ninety (90) days following
such termination, but only as to the number of shares, if any as to which the Option was exercisable immediately prior to such termination and in no event after the Expiration Date. 
 (e) In the event exercise of the Option shall require the Company to issue a fractional share of Common Stock of the Company, such fraction shall be
disregarded and the purchase price payable in connection with such exercise shall be appropriately reduced. Any such fractional share shall be carried forward and added to any shares covered by future exercise(s) of the Option. 
 (f) A “Change of Control” shall be deemed to have taken place if (i) any “person” (as such term is used in Sections 13(d) and
14(d)(2) of the Exchange Act) is or becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of
the Company’s then outstanding securities; (ii) (A) a reorganization, merger or consolidation, in each case, with respect to which persons who were shareholders of the Company immediately prior to such reorganization, merger or
consolidation do not, immediately thereafter, own more than 50% of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated company’s then outstanding voting securities or
(B) a liquidation or dissolution of the Company; or (iii) as the result of a tender offer, exchange offer, merger, consolidation, sale of assets or contested solicitation of proxies or stockholder consents or any combination of the
foregoing transactions (a “Transaction”), the persons who were directors of the Company immediately before the Transaction shall cease to constitute a majority of the Board of Directors of the Company or of any parent of or successor to
the Company immediately after the Transaction occurs. 
 (g) As used herein, “Good Reason” shall mean: 
 (i) The assignment to the Optionee of any duties inconsistent in any material adverse respect with the Optionee’s position (including status,
offices, titles and reporting requirements), authority, duties or responsibilities as in effect on March 1, 2008, or any other action by the Company which results in a diminution in such position, authority, duties or responsibilities,
excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice from the Optionee; 
 (ii) Any reduction of the Optionee’s base salary or the failure by the Company to provide the Optionee with an incentive compensation program,
welfare benefits, retirement benefits and other benefits which in the aggregate are no less favorable than the benefits to which the Optionee was entitled prior to March 1, 2008; or 
 (iii) The Company’s requiring the Optionee to be based at any office or location more than 15 miles from that location at which he or she is
employed on March 1, 2008, except for travel reasonably required in the performance of his or her responsibilities. 
 3. The Option
shall not be transferable other than by will or by the laws of descent and distribution and shall be exercisable during the Optionee’s lifetime only by the Optionee. 
 4. Option may be exercised only in writing and in the manner described in the Nabi Biopharmaceuticals Stock Options Information Brochure and the Salomon Smith Barney Automated Stock Access Program brochure, copies of
which are attached hereto. 
 2000 Equity Incentive Plan 

 5. This Option shall not be treated as an incentive stock option. 
 6. Any brokerage fees or commissions, and all taxes are the responsibility of the Optionee. 
 WITNESS the execution hereof as of this 24th day of February, 2006. 
  

			
	Nabi Biopharmaceuticals
		
	By	 	  

		 	Thomas H. McLain, Chairman
		 	Chief Executive Officer & President

 By signing this Letter Agreement below, the Optionee hereby acknowledges and agrees that
he/she has read, understands and accepts and agrees to all of the terms and conditions set forth herein and set forth in the Nabi 2000 Equity Incentive Plan and, without limitation, expressly agrees to the provisions of paragraph 2(d) set forth
above. 
  

	
	  

	Optionee Signature –
	
	  

	Print Name

 2000 Equity Incentive Plan

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]